Mitopower

• Mani Subramanian

Sources: reporter.nih.gov

• National Institute on Alcohol Abuse and Alcoholism

  U44, Novel therapy for alcoholic liver disease-associated hepatorenal syndrome, U44AA029833, $1.5M, 2021–2027, Aug 14, 2025

Sources: reporter.nih.gov

• Pharmacological profiling of intravenous MP-04: sustained NAD+ augmentation, immune modulation, and renal protection in preclinical models

  Employment, Consulting or advice, Jun 10, 2026

• Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure

  Consulting or advice, May 20, 2025

Sources: pubmed.ncbi.nlm.nih.gov